GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3326 - 3350 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G15209MJ
85
IgM Patient 3 4 mild
G15209MJ
87
IgA Patient 4 12 mild
G15209MJ
360
IgG Patient 4 12 mild
G15209MJ
54
IgM Patient 4 12 mild
G15209MJ
105
IgA Patient 1 10 moderate
G14988WV
410
IgA Patient 1 22 moderate
G14988WV
450
IgA Patient 1 6 moderate
G14988WV
290
IgG Patient 1 10 moderate
G14988WV
34
IgG Patient 1 22 moderate
G14988WV
49
IgG Patient 1 6 moderate
G14988WV
25
IgM Patient 1 10 moderate
G14988WV
69
IgM Patient 1 22 moderate
G14988WV
220
IgM Patient 1 6 moderate
G14988WV
42
IgA Patient 2 15 mild
G14988WV
380
IgA Patient 2 24 mild
G14988WV
385
IgG Patient 2 15 mild
G14988WV
162
IgG Patient 2 24 mild
G14988WV
164
IgM Patient 2 15 mild
G14988WV
203
IgM Patient 2 24 mild
G14988WV
233
IgA Patient 2 3 mild
G14988WV
371
IgG Patient 2 3 mild
G14988WV
181
IgM Patient 2 3 mild
G14988WV
255
IgA Patient 3 -180 mild
G14988WV
279
IgA Patient 3 11 mild
G14988WV
450

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024